# CDAN1

## Overview
The CDAN1 gene encodes the protein codanin-1, which is integral to chromatin organization and is implicated in congenital dyserythropoietic anemia type I (CDA-I). Codanin-1 functions as a scaffold protein, facilitating the assembly of chromatin-associated complexes and regulating histone supply during DNA replication. It interacts with various proteins, including the histone chaperone ASF1, to control the availability of histones necessary for nucleosome assembly. The protein's structure includes multiple domains, such as MIF4G and MA3, which contribute to its role in chromatin dynamics. Mutations in CDAN1 disrupt these processes, leading to the clinical manifestations of CDA-I, characterized by ineffective erythropoiesis and distinct erythroblast abnormalities (Tamary2005Clinical; Ask2012Codanin1; Sedor2024Mechanism).

## Structure
The CDAN1 gene encodes the protein codanin-1, which is involved in chromatin organization and is associated with congenital dyserythropoietic anemia type I (CDA-I). Codanin-1 contains several distinct domains that contribute to its function. It includes two MIF4G domains, a three-helix bundle of unknown function, and an MA3 domain. The MIF4G2 domain, along with a conserved central extension, facilitates the dimerization of CDAN1, while the MIF4G1 domain is interrupted by a long loop containing the B-domain, which interacts with ASF1A (Sedor2024Mechanism). 

The protein's structure is similar to CNOT1, particularly in the MIF4G and CN9BD domains, suggesting a potential role in RNA-related pathways (Swickley2020Characterization). Codanin-1 also contains helix structures, HMHA1 and HMHA2, that mimic histone H3 and bind to ASF1A, potentially interfering with histone chaperoning activity (Sedor2024Mechanism). 

Codanin-1 acts as a scaffold protein, organizing the assembly of CDIN1 and multiple ASF1A molecules within the complex (Sedor2024Mechanism). The protein is highly conserved across metazoans, although it has been lost in some taxa, such as Porifera and Nematoda (Swickley2020Characterization).

## Function
The CDAN1 gene encodes Codanin-1, a protein that plays a crucial role in regulating histone supply during DNA replication in healthy human cells. Codanin-1 is involved in the formation of a cytosolic complex with the histone chaperone Asf1, histones H3.1-H4, and Importin-4. This complex is essential for the proper supply of histones to chromatin, which is necessary for nucleosome assembly during the S-phase of the cell cycle (Ask2012Codanin1; Russo2019Characterization).

Codanin-1 acts as a negative regulator of Asf1 by sequestering it in the cytoplasm, thereby controlling the rate of DNA replication and the level of chromatin-bound Asf1. This regulation ensures that histone provision is coordinated with DNA synthesis, maintaining proper chromatin assembly and replication control (Ask2012Codanin1). The interaction between Codanin-1 and Asf1 is mediated through a conserved B-domain in Codanin-1, which is mutually exclusive with other histone chaperones like CAF-1 and HIRA (Ask2012Codanin1).

Codanin-1 is ubiquitously expressed in adult tissues and is vital for early embryonic development, indicating its fundamental biological function. Its role in histone supply and DNA replication suggests it may act as a checkpoint in chromatin replication (Ask2012Codanin1).

## Clinical Significance
Mutations in the CDAN1 gene are primarily associated with congenital dyserythropoietic anemia type I (CDA I), a rare inherited disorder characterized by ineffective erythropoiesis and distinct morphological abnormalities in erythroblasts, such as binucleated cells and chromatin bridges (Tamary2005Clinical; Roy2019The). These mutations disrupt the normal function of Codanin-1, the protein encoded by CDAN1, which plays a crucial role in chromatin assembly and DNA replication (Ask2012Codanin1; Roy2019The).

CDA I is marked by moderate to severe macrocytic anemia, jaundice, splenomegaly, and iron overload, with some patients also experiencing skeletal abnormalities (Lin2020Congenital). The disease is caused by a variety of mutations, with more than 30 unique mutations identified, primarily in exons 6 to 28 of the CDAN1 gene (Iolascon2012Clinical). These mutations lead to defects in histone metabolism and chromatin structure, contributing to the pathogenesis of CDA I (Ask2012Codanin1).

The clinical presentation of CDA I can vary significantly, with some patients requiring blood transfusions and others developing complex bone diseases (Tamary2005Clinical). Genetic testing is crucial for accurate diagnosis and management, as it helps identify the specific mutations responsible for the condition (Roy2019The).

## Interactions
The CDAN1 gene encodes the protein Codanin-1, which is involved in several critical protein interactions. Codanin-1 interacts with ASF1, a histone chaperone, by sequestering it in the cytoplasm, thereby regulating histone supply during DNA replication. This interaction is mediated through a conserved B-domain in Codanin-1, which binds to ASF1's HIRA/CAF-1 interaction pocket. This binding is mutually exclusive with other chaperones like CAF-1 and HIRA (Ask2012Codanin1).

Codanin-1 also interacts with C15Orf41, a protein implicated in congenital dyserythropoietic anemia type I (CDA I). This interaction stabilizes C15Orf41 and affects its subcellular localization, shifting it from the nucleus to the cytoplasm. The interaction is localized to the C-terminal region of Codanin-1 (Swickley2020Characterization).

Additionally, Codanin-1 is part of a cytosolic complex with ASF1, histones H3.1-H4, and Importin-4, suggesting a role in the nuclear import of histones. This complex formation is independent of histone binding, as demonstrated by studies with Asf1 mutants (Ask2012Codanin1). These interactions highlight Codanin-1's role as a scaffold protein in chromatin assembly and regulation.


## References


[1. (Tamary2005Clinical) Hannah Tamary, Orly Dgany, Alexis Proust, Tatyana Krasnov, Nili Avidan, Tal Eidelitz‐Markus, Gil Tchernia, David Geneviève, Valérie Cormier‐Daire, Brigitte Bader‐Meunier, Corinne Ferrero‐Vacher, Martine Munzer, Ralph Gruppo, Eithan Fibach, Osnat Konen, Isaac Yaniv, and Jean Delaunay. Clinical and molecular variability in congenital dyserythropoietic anaemia type i. British Journal of Haematology, 130(4):628–634, July 2005. URL: http://dx.doi.org/10.1111/j.1365-2141.2005.05642.x, doi:10.1111/j.1365-2141.2005.05642.x. This article has 46 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/j.1365-2141.2005.05642.x)

2. (Sedor2024Mechanism) Mechanism of ASF1 Inhibition by CDAN1. This article has 0 citations.

[3. (Lin2020Congenital) Pei‐Chin Lin, Chao‐Neng Cheng, Hsi‐Yuan Huang, Yu‐Hsin Tseng, Ya‐Sian Chang, Chien‐Yu Lin, and Jan‐Gowth Chang. Congenital dyserythropoiesis anemia type ia with a novel cdan1 mutation diagnosed by whole exome sequencing. Molecular Genetics &amp; Genomic Medicine, March 2020. URL: http://dx.doi.org/10.1002/mgg3.1220, doi:10.1002/mgg3.1220. This article has 0 citations.](https://doi.org/10.1002/mgg3.1220)

[4. (Ask2012Codanin1) Katrine Ask, Zuzana Jasencakova, Patrice Menard, Yunpeng Feng, Geneviève Almouzni, and Anja Groth. Codanin-1, mutated in the anaemic disease cdai, regulates asf1 function in s-phase histone supply: codanin-1, a novel regulator of histone supply. The EMBO Journal, 31(8):2013–2023, March 2012. URL: http://dx.doi.org/10.1038/emboj.2012.55, doi:10.1038/emboj.2012.55. This article has 63 citations.](https://doi.org/10.1038/emboj.2012.55)

[5. (Roy2019The) Noémi B. A. Roy and Christian Babbs. The pathogenesis, diagnosis and management of congenital dyserythropoietic anaemia type i. British Journal of Haematology, 185(3):436–449, March 2019. URL: http://dx.doi.org/10.1111/bjh.15817, doi:10.1111/bjh.15817. This article has 45 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/bjh.15817)

[6. (Swickley2020Characterization) Grace Swickley, Yehoshua Bloch, Lidor Malka, Adi Meiri, Sharon Noy-Lotan, Amiel Yanai, Hannah Tamary, and Benny Motro. Characterization of the interactions between codanin-1 and c15orf41, two proteins implicated in congenital dyserythropoietic anemia type i disease. BMC Molecular and Cell Biology, March 2020. URL: http://dx.doi.org/10.1186/s12860-020-00258-1, doi:10.1186/s12860-020-00258-1. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12860-020-00258-1)

[7. (Russo2019Characterization) Roberta Russo, Roberta Marra, Immacolata Andolfo, Gianluca De Rosa, Barbara Eleni Rosato, Francesco Manna, Antonella Gambale, Maddalena Raia, Sule Unal, Susanna Barella, and Achille Iolascon. Characterization of two cases of congenital dyserythropoietic anemia type i shed light on the uncharacterized c15orf41 protein. Frontiers in Physiology, May 2019. URL: http://dx.doi.org/10.3389/fphys.2019.00621, doi:10.3389/fphys.2019.00621. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphys.2019.00621)

[8. (Iolascon2012Clinical) A. Iolascon, M. R. Esposito, and R. Russo. Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach. Haematologica, 97(12):1786–1794, October 2012. URL: http://dx.doi.org/10.3324/haematol.2012.072207, doi:10.3324/haematol.2012.072207. This article has 65 citations.](https://doi.org/10.3324/haematol.2012.072207)